Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""CENTRAL nervous system"" wg kryterium: Temat


Tytuł :
Primary angiitis of the CNS and ANCA-associated vasculitis: from pathology to treatment.
Autorzy :
Sherri A; Department of Rheumatology, Medical University of Lodz, Łódź, Poland. .
Mortada MM; Department of Immunology and Allergy, Medical University of Lodz, Łódź, Poland.
Makowska J; Department of Rheumatology, Medical University of Lodz, Łódź, Poland.
Lewandowska-Polak A; Department of Rheumatology, Medical University of Lodz, Łódź, Poland.
Pokaż więcej
Źródło :
Rheumatology international [Rheumatol Int] 2024 Feb; Vol. 44 (2), pp. 211-222. Date of Electronic Publication: 2023 Sep 30.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Vasculitis, Central Nervous System*/diagnosis
Vasculitis, Central Nervous System*/etiology
Vasculitis, Central Nervous System*/therapy
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis*/complications
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis*/diagnosis
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis*/therapy
Cognitive Dysfunction*
Humans ; Central Nervous System
SCR Disease Name :
Primary angiitis of the central nervous system
Czasopismo naukowe
Tytuł :
Impact of central nervous system metastasis after complete resection of lung adenocarcinomas harboring common EGFR mutation - A real-world database study in Japan: The CReGYT-01 EGFR study.
Autorzy :
Katsumata S; Division of Thoracic Surgery, Shizuoka Cancer Center, Shizuoka, Japan. Electronic address: .
Shimokawa M; Department of Biostatistics, Graduate School of Medicine, Yamaguchi University, Yamaguchi, Japan.
Hamada A; Division of Thoracic Surgery, Department of Surgery, Kindai University Faculty of Medicine, Osaka-Sayama, Japan.
Haratake N; Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Nomura K; Department of Thoracic Surgery, National Cancer Center Hospital East, Kashiwa, Japan.
Fujino K; Department of Thoracic Surgery, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan.
Yoshikawa M; Department of Thoracic Surgery, Okayama University Hospital, Okayama, Japan.
Suzawa K; Department of Thoracic Surgery, Okayama University Hospital, Okayama, Japan.
Shien K; Department of Thoracic Surgery, Okayama University Hospital, Okayama, Japan.
Suda K; Division of Thoracic Surgery, Department of Surgery, Kindai University Faculty of Medicine, Osaka-Sayama, Japan.
Ohara S; Division of Thoracic Surgery, Department of Surgery, Kindai University Faculty of Medicine, Osaka-Sayama, Japan.
Fukuda S; Division of Thoracic Surgery, Department of Surgery, Kindai University Faculty of Medicine, Osaka-Sayama, Japan.
Kinoshita F; Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan; Department of Thoracic Oncology, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan.
Hayasaka K; Department of Thoracic Surgery, Institute of Development, Aging and Cancer, Tohoku University, Sendai, Japan.
Notsuda H; Department of Thoracic Surgery, Institute of Development, Aging and Cancer, Tohoku University, Sendai, Japan.
Takamori S; Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan; Department of Thoracic and Breast Surgery, Oita University Faculty of Medicine, Oita, Japan.
Muto S; Department of Chest Surgery, Fukushima Medical University School of Medicine, Fukushima, Japan.
Takanashi Y; First Department of Surgery, Hamamatsu University School of Medicine, Shizuoka, Japan.
Mizuno K; First Department of Surgery, Hamamatsu University School of Medicine, Shizuoka, Japan.
Kawase A; First Department of Surgery, Hamamatsu University School of Medicine, Shizuoka, Japan.
Hayakawa T; First Department of Surgery, Hamamatsu University School of Medicine, Shizuoka, Japan.
Sekihara K; First Department of Surgery, Hamamatsu University School of Medicine, Shizuoka, Japan.
Toda M; Departments of General Thoracic Surgery, Kansai Rosai Hospital, Japan Organization of Occupational Health and Safety, Hyogo, Japan.
Matsuo S; Department of Cardiovascular Surgery, Nihonkai General Hospital, Sakata, Japan.
Takegahara K; Department of Thoracic Surgery, Hyogo College of Medicine, Nishinomiya, Japan.
Hashimoto M; Department of Thoracic Surgery, Hyogo College of Medicine, Nishinomiya, Japan.
Nakahashi K; Department of Thoracic Surgery, Yamagata Prefectural Central Hospital, Japan.
Endo M; Department of Thoracic Surgery, Yamagata Prefectural Central Hospital, Japan.
Ozawa H; Department of Thoracic Surgery, Shimada General Medical Center, Shizuoka, Japan.
Fujikawa R; Department of Thoracic Surgery, Shimada General Medical Center, Shizuoka, Japan.
Tomioka Y; Division of Thoracic Surgery, Department of Surgery, Faculty of Medicine, Shimane University, Shimane, Japan.
Namba K; Division of Thoracic Surgery, Department of Surgery, Faculty of Medicine, Shimane University, Shimane, Japan.
Matsubara T; Department of Thoracic Surgery, Kitakyushu Municipal Medical Center, Fukuoka, Japan.
Suzuki J; Department of Surgery II, Faculty of Medicine, Yamagata University, Yamagata, Japan.
Watanabe H; Department of Surgery II, Faculty of Medicine, Yamagata University, Yamagata, Japan.
Takada K; Department of Surgery, Saiseikai Fukuoka General Hospital, Fukuoka, Japan.
Hoshino H; Department of Surgery, National Hospital Organization, Okinawa National Hospital, Okinawa, Japan.
Kaiho T; Department of General Thoracic Surgery, Chiba University Graduate School of Medicine, Chiba, Japan.
Toyoda T; Department of General Thoracic Surgery, Chiba University Graduate School of Medicine, Chiba, Japan.
Kouki Y; Center for Clinical Research, Yamaguchi University Hospital, Yamaguchi, Japan.
Shiono S; Department of Surgery II, Faculty of Medicine, Yamagata University, Yamagata, Japan.
Soh J; Division of Thoracic Surgery, Department of Surgery, Kindai University Faculty of Medicine, Osaka-Sayama, Japan.
Ohde Y; Division of Thoracic Surgery, Shizuoka Cancer Center, Shizuoka, Japan.
Pokaż więcej
Źródło :
European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2024 Apr; Vol. 201, pp. 113951. Date of Electronic Publication: 2024 Feb 22.
Typ publikacji :
Observational Study; Multicenter Study; Journal Article
MeSH Terms :
Lung Neoplasms*/genetics
Lung Neoplasms*/surgery
Lung Neoplasms*/drug therapy
Antineoplastic Agents*/therapeutic use
Adenocarcinoma of Lung*/genetics
Adenocarcinoma of Lung*/surgery
Adenocarcinoma of Lung*/drug therapy
Central Nervous System Neoplasms*/genetics
Central Nervous System Neoplasms*/surgery
Central Nervous System Neoplasms*/drug therapy
Humans ; Japan ; Neoplasm Recurrence, Local/genetics ; Neoplasm Recurrence, Local/drug therapy ; ErbB Receptors/genetics ; Mutation ; Recurrence ; Central Nervous System/pathology ; Protein Kinase Inhibitors/therapeutic use ; Retrospective Studies
Czasopismo naukowe
Tytuł :
Central Nervous System Metastases in Pediatric Patients With Ewing Sarcoma.
Autorzy :
Slatnick LR; Department of Pediatrics, University of Utah, Division of Hematology/Oncology, Primary Children's Hospital, Salt Lake City, UT.
Cost C; Department of Pediatrics, University of Colorado Anschutz Medical Campus and Center for Cancer and Blood Disorders, Children's Hospital Colorado.
Garrington T; Department of Pediatrics, University of Colorado Anschutz Medical Campus and Center for Cancer and Blood Disorders, Children's Hospital Colorado.
Donaldson N; Department of Orthopedic Surgery, University of Colorado Anschutz Medical Campus, Aurora, CO.
Macy ME; Department of Pediatrics, University of Colorado Anschutz Medical Campus and Center for Cancer and Blood Disorders, Children's Hospital Colorado.
Pokaż więcej
Źródło :
Journal of pediatric hematology/oncology [J Pediatr Hematol Oncol] 2024 Mar 01; Vol. 46 (2), pp. e180-e183. Date of Electronic Publication: 2024 Feb 02.
Typ publikacji :
Journal Article
MeSH Terms :
Sarcoma, Ewing*/pathology
Central Nervous System Neoplasms*/therapy
Central Nervous System Neoplasms*/secondary
Neoplasms, Second Primary*
Central Nervous System Diseases*
Child ; Humans ; Incidence ; Retrospective Studies ; Central Nervous System/pathology
Czasopismo naukowe
Tytuł :
Central Nervous System Lymphoma Mimicking Demyelinating Disease-A Case Report.
Autorzy :
Foster MA; Department of Neuroinflammation (MAF, SC), UCL Queen Square Institute of Neurology, Faculty of Brain Sciences, University College London, London, United Kingdom; Adnexal Service, Moorfields Eye Hospital NHS Foundation Trust (GR), London, United Kingdom; Department of Clinical Oncology (PNP), St Bartholomew's Hospital, London, United Kingdom; Department of Clinical and Experimental Epilepsy (MT), UCL Queen Square Institute of Neurology, Faculty of Brain Sciences, University College London, London, United Kingdom; Lysholm Department of Neuroradiology (ID), National Hospital for Neurology and Neurosurgery, London, United Kingdom; and Strabismus and Neuro-Ophthalmology Service (JA), Moorfields Eye Hospital NHS Foundation Trust, London, United Kingdom.
Collorone S
Rose G
Plowman PN
Thom M
Davagnanam I
Acheson J
Toosy AT
Pokaż więcej
Źródło :
Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society [J Neuroophthalmol] 2024 Mar 01; Vol. 44 (1), pp. e55-e57. Date of Electronic Publication: 2022 Jun 08.
Typ publikacji :
Case Reports; Journal Article
MeSH Terms :
Central Nervous System Neoplasms*/diagnosis
Lymphoma*/diagnosis
Central Nervous System Diseases*
Demyelinating Diseases*/diagnosis
Humans ; Central Nervous System/pathology
Czasopismo naukowe
Tytuł :
Central nervous system metastases in breast cancer patients with germline BRCA pathogenic variants compared to non-carriers: a matched-pair analysis.
Autorzy :
Ben-Zion Berliner M; Breast cancer Unit, Davidoff Cancer Center, Rabin Medical Center-Beilinson Hospital, Petach Tikva, Israel. .
Yust-Katz S; Neuro-Oncology Unit, Davidoff Cancer Center, Rabin Medical Center-Beilinson Hospital, Petach Tikva, Israel.; Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Lavie I; Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Goldberg Y; The Raphael Recanati Genetics Institute, Rabin Medical Center-Beilinson Hospital, Petach Tikva, Israel.; Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Kedar I; The Raphael Recanati Genetics Institute, Rabin Medical Center-Beilinson Hospital, Petach Tikva, Israel.
Yerushalmi R; Breast cancer Unit, Davidoff Cancer Center, Rabin Medical Center-Beilinson Hospital, Petach Tikva, Israel.; Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Pokaż więcej
Źródło :
BMC cancer [BMC Cancer] 2024 Feb 16; Vol. 24 (1), pp. 219. Date of Electronic Publication: 2024 Feb 16.
Typ publikacji :
Journal Article
MeSH Terms :
BRCA1 Protein*/genetics
BRCA2 Protein*/genetics
Breast Neoplasms*/pathology
Central Nervous System Neoplasms*/genetics
Central Nervous System Neoplasms*/secondary
Female ; Humans ; Central Nervous System ; Germ Cells/pathology ; Germ-Line Mutation ; Matched-Pair Analysis ; Prognosis ; Retrospective Studies
Czasopismo naukowe
Tytuł :
In Vivo Reprogramming Using Yamanaka Factors in the CNS: A Scoping Review.
Autorzy :
Cho HE; Rehabilitation Institute of Neuromuscular Disease, Yonsei University College of Medicine, Seoul 06229, Republic of Korea.; Department of Rehabilitation Medicine, Gangnam Severance Hospital, Seoul 06229, Republic of Korea.
Lee S; Graduate Program of Biomedical Engineering, Yonsei University College of Medicine, Seoul 03722, Republic of Korea.; Department of Rehabilitation Medicine, Graduate School of Medical Science, Brain Korea 21 Project, Yonsei University College of Medicine, Seoul 03722, Republic of Korea.
Seo JH; Department of Rehabilitation Medicine, Graduate School of Medical Science, Brain Korea 21 Project, Yonsei University College of Medicine, Seoul 03722, Republic of Korea.; Research Institute of Rehabilitation Medicine, Yonsei University College of Medicine, Seoul 03722, Republic of Korea.
Kang SW; Rehabilitation Institute of Neuromuscular Disease, Yonsei University College of Medicine, Seoul 06229, Republic of Korea.; Department of Rehabilitation Medicine, Gangnam Severance Hospital, Seoul 06229, Republic of Korea.
Choi WA; Rehabilitation Institute of Neuromuscular Disease, Yonsei University College of Medicine, Seoul 06229, Republic of Korea.; Department of Rehabilitation Medicine, Gangnam Severance Hospital, Seoul 06229, Republic of Korea.
Cho SR; Rehabilitation Institute of Neuromuscular Disease, Yonsei University College of Medicine, Seoul 06229, Republic of Korea.; Graduate Program of Biomedical Engineering, Yonsei University College of Medicine, Seoul 03722, Republic of Korea.; Department of Rehabilitation Medicine, Graduate School of Medical Science, Brain Korea 21 Project, Yonsei University College of Medicine, Seoul 03722, Republic of Korea.; Research Institute of Rehabilitation Medicine, Yonsei University College of Medicine, Seoul 03722, Republic of Korea.
Pokaż więcej
Źródło :
Cells [Cells] 2024 Feb 15; Vol. 13 (4). Date of Electronic Publication: 2024 Feb 15.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Cellular Reprogramming*
Central Nervous System Diseases*/genetics
Central Nervous System Diseases*/therapy
Animals ; Humans ; Octamer Transcription Factor-3/genetics ; Transcription Factors/genetics ; Central Nervous System
Czasopismo naukowe
Tytuł :
Empirical Analysis of Drug Targets for Nervous System Disorders.
Autorzy :
Mueller LG; Division of Geriatric Medicine and Gerontology, Johns Hopkins School of Medicine, Baltimore, Maryland 21205, United States.; Johns Hopkins Drug Discovery, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, United States.
Slusher BS; Johns Hopkins Drug Discovery, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, United States.; Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, United States.
Tsukamoto T; Johns Hopkins Drug Discovery, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, United States.; Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, United States.
Pokaż więcej
Źródło :
ACS chemical neuroscience [ACS Chem Neurosci] 2024 Feb 07; Vol. 15 (3), pp. 394-399. Date of Electronic Publication: 2024 Jan 18.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Nervous System Diseases*/metabolism
Central Nervous System Diseases*/drug therapy
Humans ; Central Nervous System Agents/chemistry ; Central Nervous System/metabolism ; Blood-Brain Barrier/metabolism ; Drug Discovery
Czasopismo naukowe
Tytuł :
Letter to editor: C‑reactive protein levels, the prognostic nutritional index, and the lactate dehydrogenase‑to‑lymphocyte ratio are important prognostic factors in primary central nervous system lymphoma: a single‑center study of 223 patients.
Autorzy :
Un Nisa Mughal Z; Department of Medicine, Jinnah Sindh Medical University, Rafiqi H J Shaheed Road, Karachi, Pakistan.
Haseeb A; Department of Medicine, Jinnah Sindh Medical University, Rafiqi H J Shaheed Road, Karachi, Pakistan. .
Pokaż więcej
Źródło :
Neurosurgical review [Neurosurg Rev] 2024 Apr 11; Vol. 47 (1), pp. 146. Date of Electronic Publication: 2024 Apr 11.
Typ publikacji :
Letter
MeSH Terms :
C-Reactive Protein*/analysis
Central Nervous System Neoplasms*/diagnosis
Lactate Dehydrogenases*/analysis
Lymphocytes*
Lymphoma*/diagnosis
Humans ; Central Nervous System ; Nutrition Assessment ; Prognosis ; Retrospective Studies
Opinia redakcyjna
Tytuł :
A Systematic Review and Clinical Presentation of Central Nervous System Complications of Severe Acute Respiratory Syndrome Coronavirus 2 in Hospitalized Pediatric Patients During the Coronavirus Disease 2019 Pandemic in Israel.
Autorzy :
Jurkowicz M; Faculty of Medicine, Department of Epidemiology and Preventive Medicine, School of Public Health, Tel Aviv University, Tel Aviv, Israel; Central Virology Laboratory, Ministry of Health, Chaim Sheba Medical Center, Ramat Gan, Israel; Pediatric Infectious Disease Unit, The Edmond and Lily Safra Children's Hospital, Chaim Sheba Medical Center, Ramat Gan, Israel.
Leibovitz E; Pediatric Infectious Disease Unit, The Edmond and Lily Safra Children's Hospital, Chaim Sheba Medical Center, Ramat Gan, Israel.
Ben-Zeev B; Pediatric Neurology Unit, The Edmond and Lily Safra Children's Hospital, Chaim Sheba Medical Center, Ramat Gan, Israel.
Keller N; Ariel University, Ariel, Israel.
Kriger O; Pediatric Infectious Disease Unit, The Edmond and Lily Safra Children's Hospital, Chaim Sheba Medical Center, Ramat Gan, Israel.
Sherman G; Pediatric Infectious Disease Unit, The Edmond and Lily Safra Children's Hospital, Chaim Sheba Medical Center, Ramat Gan, Israel.
Amit S; Clinical Microbiology Laboratory, Sheba Medical Center, Ramat-Gan, Israel.
Barkai G; Pediatric Infectious Disease Unit, The Edmond and Lily Safra Children's Hospital, Chaim Sheba Medical Center, Ramat Gan, Israel.
Mandelboim M; Faculty of Medicine, Department of Epidemiology and Preventive Medicine, School of Public Health, Tel Aviv University, Tel Aviv, Israel; Central Virology Laboratory, Ministry of Health, Chaim Sheba Medical Center, Ramat Gan, Israel.
Stein M; Pediatric Infectious Disease Unit, The Edmond and Lily Safra Children's Hospital, Chaim Sheba Medical Center, Ramat Gan, Israel; Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. Electronic address: .
Pokaż więcej
Źródło :
Pediatric neurology [Pediatr Neurol] 2024 Apr; Vol. 153, pp. 68-76. Date of Electronic Publication: 2024 Jan 11.
Typ publikacji :
Systematic Review; Journal Article
MeSH Terms :
COVID-19*/complications
COVID-19*/epidemiology
Influenza, Human*/complications
Influenza, Human*/epidemiology
Seizures, Febrile*
Central Nervous System Diseases*
Humans ; Child ; SARS-CoV-2 ; Israel/epidemiology ; Pandemics ; Central Nervous System
Czasopismo naukowe
Tytuł :
Comprehensive CCM3 Mutational Analysis in Two Patients with Syndromic Cerebral Cavernous Malformation.
Autorzy :
da Fontoura Galvão G; Programa de Pós-Graduação Em Neurologia, Laboratório de Neurociências Translacional, Universidade Federal Do Estado Do Rio de Janeiro, Rio de Janeiro RJ, Brazil.; Departamento de Neurocirurgia, Hospital Universitário Clementino Fraga Filho, Universidade Federal Do Rio de Janeiro, Rio de Janeiro RJ, Brazil.
da Silva EV; Programa de Pós-Graduação Em Neurologia, Laboratório de Neurociências Translacional, Universidade Federal Do Estado Do Rio de Janeiro, Rio de Janeiro RJ, Brazil.; Programa de Pós-Graduação Em Neurologia E Neurociências, Universidade Federal Fluminense, Rio de Janeiro RJ, Brazil.
Trefilio LM; Programa de Pós-Graduação Em Neurologia, Laboratório de Neurociências Translacional, Universidade Federal Do Estado Do Rio de Janeiro, Rio de Janeiro RJ, Brazil.
Alves-Leon SV; Programa de Pós-Graduação Em Neurologia, Laboratório de Neurociências Translacional, Universidade Federal Do Estado Do Rio de Janeiro, Rio de Janeiro RJ, Brazil.; Departamento de Neurologia, Hospital Universitário Clementino Fraga Filho, Universidade Federal Do Rio de Janeiro, Rio de Janeiro RJ, Brazil.
Fontes-Dantas FL; Programa de Pós-Graduação Em Neurologia, Laboratório de Neurociências Translacional, Universidade Federal Do Estado Do Rio de Janeiro, Rio de Janeiro RJ, Brazil. .; Departamento de Farmacologia E Psicobiologia, Instituto de Biologia Roberto Alcântara Gomes, Universidade Estadual Do Rio de Janeiro, Rio de Janeiro RJ, Brazil. .
de Souza JM; Programa de Pós-Graduação Em Neurologia, Laboratório de Neurociências Translacional, Universidade Federal Do Estado Do Rio de Janeiro, Rio de Janeiro RJ, Brazil. .; Departamento de Neurocirurgia, Hospital Universitário Clementino Fraga Filho, Universidade Federal Do Rio de Janeiro, Rio de Janeiro RJ, Brazil. .
Pokaż więcej
Źródło :
Translational stroke research [Transl Stroke Res] 2024 Apr; Vol. 15 (2), pp. 411-421. Date of Electronic Publication: 2023 Feb 01.
Typ publikacji :
Case Reports; Journal Article
MeSH Terms :
Hemangioma, Cavernous, Central Nervous System*/diagnostic imaging
Hemangioma, Cavernous, Central Nervous System*/genetics
Humans ; Central Nervous System ; Mutation/genetics ; Phenotype ; Proto-Oncogene Proteins/genetics
Czasopismo naukowe
Tytuł :
Clinical factors for central nervous system progression and survival in primary vitreoretinal lymphoma.
Autorzy :
Motomura Y; Department of Hematology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University (TMDU), Tokyo, Japan.
Yoshifuji K; Department of Hematology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University (TMDU), Tokyo, Japan.
Tachibana T; Department of Hematology, Kanagawa Cancer Center, Yokohama, Japan.
Takase H; Department of Ophthalmology and Visual Science, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University (TMDU), Tokyo, Japan.
Arai A; Department of Hematology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University (TMDU), Tokyo, Japan.; Department of Hematology and Oncology, St. Marianna University School of Medicine, Kawasaki, Kanagawa, Japan.; Department of Hematology and Biophysical Systems Analysis, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University (TMDU), Tokyo, Japan.
Tanaka K; Department of Hematology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University (TMDU), Tokyo, Japan.
Okada K; Department of Hematology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University (TMDU), Tokyo, Japan.
Nogami A; Department of Laboratory Medicine, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University (TMDU), Tokyo, Japan.
Umezawa Y; Department of Hematology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University (TMDU), Tokyo, Japan.
Sakashita C; Department of Hematology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University (TMDU), Tokyo, Japan.
Yamamoto M; Department of Hematology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University (TMDU), Tokyo, Japan.
Mori T; Department of Hematology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University (TMDU), Tokyo, Japan.
Nagao T; Department of Hematology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University (TMDU), Tokyo, Japan.
Pokaż więcej
Źródło :
British journal of haematology [Br J Haematol] 2024 Apr; Vol. 204 (4), pp. 1279-1287. Date of Electronic Publication: 2023 Dec 22.
Typ publikacji :
Journal Article
MeSH Terms :
Retinal Neoplasms*/drug therapy
Retinal Neoplasms*/pathology
Lymphoma*/drug therapy
Central Nervous System Neoplasms*
Humans ; Retrospective Studies ; Vitreous Body/pathology ; Central Nervous System/pathology ; Methotrexate
Czasopismo naukowe
Tytuł :
Intraoperative pathologic diagnosis of central nervous system lymphomas: A comparison of frozen and permanent section diagnoses, and the significance of preoperative imaging.
Autorzy :
Kahraman A; Department of Pathology, Ataturk Training and Research Hospital, Izmir Katip Celebi University, Türkiye.
Dirilenoğlu F; Department of Pathology, Faculty of Medicine, Near East University, Nicosia, Cyprus. Electronic address: .
Güzeliş İ; Department of Pathology, Ataturk Training and Research Hospital, Izmir Katip Celebi University, Türkiye.
Çetinoğlu K; Department of Radiology, Ataturk Training and Research Hospital, Izmir Katip Celebi University, Türkiye.
Pokaż więcej
Źródło :
Annals of diagnostic pathology [Ann Diagn Pathol] 2024 Apr; Vol. 69, pp. 152246. Date of Electronic Publication: 2023 Dec 14.
Typ publikacji :
Journal Article
MeSH Terms :
Central Nervous System Neoplasms*/diagnostic imaging
Lymphoma, Non-Hodgkin*
Lymphoma*/diagnostic imaging
Lymphoma*/pathology
Humans ; Female ; Middle Aged ; Male ; Reproducibility of Results ; Frozen Sections/methods ; Central Nervous System/pathology
Czasopismo naukowe
Tytuł :
Prevalence and characteristics of patients prescribed opioids and central nervous system depression agents on discharge to hospice care.
Autorzy :
Nguyen CT; Division of Palliative Care, Medstar Georgetown University Hospital, Washington, DC, USA.
McPherson ML; Department of Pharmacy Practice, Sciences, and Health Outcomes Research, University of Maryland School of Pharmacy, Baltimore, MD, USA.
Noble BN; Department of Quantitative Health Sciences, Mayo Clinic, Scottsdale, AZ, USA.
Furuno JP; Department of Pharmacy Practice, Oregon State University College of Pharmacy, Portland, OR, USA.
Pokaż więcej
Źródło :
Annals of palliative medicine [Ann Palliat Med] 2024 Mar; Vol. 13 (2), pp. 240-248. Date of Electronic Publication: 2024 Mar 06.
Typ publikacji :
Journal Article
MeSH Terms :
Hospice Care*
Central Nervous System Depressants*
Neoplasms*/drug therapy
Adult ; Humans ; Female ; Aged ; Adolescent ; Male ; Analgesics, Opioid/therapeutic use ; Patient Discharge ; Prevalence ; Cross-Sectional Studies ; Depression ; Morphine ; Benzodiazepines ; Central Nervous System ; Retrospective Studies
Czasopismo naukowe
Tytuł :
The effectiveness and safety of proton beam radiation therapy in children and young adults with Central Nervous System (CNS) tumours: a systematic review.
Autorzy :
Wilson JS; Cancer Research UK Clinical Trials Unit (CRCTU), Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK. .
Main C; Cancer Research UK Clinical Trials Unit (CRCTU), Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK.
Thorp N; The Clatterbridge Cancer Centre, Liverpool, UK.; The Christie Hospital Foundation Trust Proton Beam Therapy Centre, Manchester, UK.
Taylor RE; College of Medicine, Swansea University, Swansea, UK.
Majothi S; Cancer Research UK Clinical Trials Unit (CRCTU), Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK.
Kearns PR; Cancer Research UK Clinical Trials Unit (CRCTU), Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK.; Birmingham Women's and Children's Hospital NHS Foundation Trust, Birmingham, UK.; National Institute for Health Research (NIHR) Birmingham Biomedical Research Centre, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.
English M; Birmingham Women's and Children's Hospital NHS Foundation Trust, Birmingham, UK.
Dandapani M; Children's Brain Tumour Research Centre, University of Nottingham, Nottingham, UK.; Queen's Medical Centre, Nottingham University Hospitals' NHS Trust, Nottingham, UK.
Phillips R; Centre for Reviews and Dissemination (CRD), University of York, York, UK.
Wheatley K; Cancer Research UK Clinical Trials Unit (CRCTU), Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK.
Pizer B; Alder Hey Children's NHS Foundation Trust, Liverpool, UK.; University of Liverpool, Liverpool, UK.
Pokaż więcej
Źródło :
Journal of neuro-oncology [J Neurooncol] 2024 Mar; Vol. 167 (1), pp. 1-34. Date of Electronic Publication: 2024 Jan 31.
Typ publikacji :
Systematic Review; Journal Article; Review
MeSH Terms :
Proton Therapy*/adverse effects
Proton Therapy*/methods
Central Nervous System Neoplasms*/radiotherapy
Central Nervous System Neoplasms*/etiology
Pituitary Neoplasms*
Cerebellar Neoplasms*/etiology
Child ; Humans ; Young Adult ; Quality of Life ; Central Nervous System
Czasopismo naukowe
Tytuł :
Patterns and Outcomes of Acute Central Nervous System Complications During Treatment of Childhood Acute Lymphoblastic Leukemia: A Single-center Experience.
Autorzy :
Hamoda A; Department of Pediatric Oncology, National Cancer Institute - Cairo University.; Department of Pediatric Oncology, Children Cancer Hospital, Egypt (57357 Hospital), Cairo.
Bedair M; Department of Pediatric Oncology, Damietta Cancer Institute, Damietta.
Semary SF; Department of Pediatric Oncology, Children Cancer Hospital, Egypt (57357 Hospital), Cairo.; Department of Clinical Oncology, Faculty of Medicine, Beni-Suef University, Beni-Suef, Egypt.
Youssef A; Department of Radiodiagnosis, National Cancer Institute - Cairo University.; Department of Radiodiagnosis, Children Cancer Hospital, Egypt (57357 Hospital), Cairo.
Hafez H; Department of Pediatric Oncology, National Cancer Institute - Cairo University.
Pokaż więcej
Źródło :
Journal of pediatric hematology/oncology [J Pediatr Hematol Oncol] 2024 Mar 01; Vol. 46 (2), pp. 72-79. Date of Electronic Publication: 2023 Dec 22.
Typ publikacji :
Journal Article
MeSH Terms :
Posterior Leukoencephalopathy Syndrome*
Precursor Cell Lymphoblastic Leukemia-Lymphoma*/complications
Precursor Cell Lymphoblastic Leukemia-Lymphoma*/drug therapy
Central Nervous System Diseases*/chemically induced
Central Nervous System Diseases*/epidemiology
Child ; Humans ; Retrospective Studies ; Central Nervous System
Czasopismo naukowe
Tytuł :
Balanced transformer: efficient classification of glioblastoma and primary central nervous system lymphoma.
Autorzy :
Wang S; Department of Electronic Engineering, College of Communication Engineering, Jilin University, Changchun 130012, People's Republic of China.
Wu J; Department of Electronic Engineering, College of Communication Engineering, Jilin University, Changchun 130012, People's Republic of China.
Chen M; Department of Electronic Engineering, College of Communication Engineering, Jilin University, Changchun 130012, People's Republic of China.
Huang S; Department of Radiology, the Second Hospital of Jilin University, Changchun 130012, People's Republic of China.
Huang Q; Department of Radiology, the Second Hospital of Jilin University, Changchun 130012, People's Republic of China.
Pokaż więcej
Źródło :
Physics in medicine and biology [Phys Med Biol] 2024 Feb 15; Vol. 69 (4). Date of Electronic Publication: 2024 Feb 15.
Typ publikacji :
Journal Article
MeSH Terms :
Glioblastoma*/diagnostic imaging
Glioblastoma*/pathology
Lymphoma*/diagnostic imaging
Lymphoma*/pathology
Brain Neoplasms*/pathology
Central Nervous System Neoplasms*/diagnostic imaging
Central Nervous System Neoplasms*/pathology
Humans ; Diagnosis, Differential ; Magnetic Resonance Imaging/methods ; Central Nervous System/pathology
Czasopismo naukowe
Tytuł :
Prognostic value of Beta 2-Microglobulinin in cerebrospinal fluid in primary central nervous system lymphoma.
Autorzy :
Bertucci A; APHM, CHU Timone, Service de Neurooncologie, Marseille, France.
Boucard C; APHM, CHU Timone, Service de Neurooncologie, Marseille, France.
Harlay V; APHM, CHU Timone, Service de Neurooncologie, Marseille, France.
Appay R; APHM, CHU Timone, Service d'anatomopathologie, Marseille, France; Aix-Marseille Univ, CNRS, INP, Inst Neurophysiopathol, Marseille, France.
Petrirena G; APHM, CHU Timone, Service de Neurooncologie, Marseille, France.
Barrié M; APHM, CHU Timone, Service de Neurooncologie, Marseille, France.
Chinot O; APHM, CHU Timone, Service de Neurooncologie, Marseille, France; Aix-Marseille Univ, CNRS, INP, Inst Neurophysiopathol, Marseille, France.
Tabouret E; APHM, CHU Timone, Service de Neurooncologie, Marseille, France; Aix-Marseille Univ, CNRS, INP, Inst Neurophysiopathol, Marseille, France. Electronic address: .
Pokaż więcej
Źródło :
Journal of the neurological sciences [J Neurol Sci] 2024 Feb 15; Vol. 457, pp. 122847. Date of Electronic Publication: 2023 Dec 18.
Typ publikacji :
Letter
MeSH Terms :
Central Nervous System Neoplasms*/diagnosis
Lymphoma*/diagnosis
Humans ; Prognosis ; Sensitivity and Specificity ; Central Nervous System
Opinia redakcyjna
Tytuł :
Entirely noninvasive outcome prediction in central nervous system lymphomas using circulating tumor DNA.
Autorzy :
Heger JM; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Medical Faculty and University Hospital Cologne, Cologne, Germany.; Cancer Center Cologne Essen (CCCE), Cologne, Germany.; Cologne Lymphoma Working Group, Cologne, Germany.
Mattlener J; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Medical Faculty and University Hospital Cologne, Cologne, Germany.; Cancer Center Cologne Essen (CCCE), Cologne, Germany.; German Hodgkin Study Group, Cologne, Germany.
Schneider J; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Medical Faculty and University Hospital Cologne, Cologne, Germany.; Cancer Center Cologne Essen (CCCE), Cologne, Germany.
Gödel P; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Medical Faculty and University Hospital Cologne, Cologne, Germany.; Cologne Lymphoma Working Group, Cologne, Germany.
Sieg N; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Medical Faculty and University Hospital Cologne, Cologne, Germany.; Cancer Center Cologne Essen (CCCE), Cologne, Germany.; Cologne Lymphoma Working Group, Cologne, Germany.
Ullrich F; Department of Hematology and Stem Cell Transplantation, West German Cancer Center and German Cancer Consortium (Deutsches Konsortium für Translationale Krebsforschung partner site Essen), University Hospital Essen, University of Duisburg-Essen, Essen, Germany.; CCCE, Essen, Germany.
Lewis R; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Medical Faculty and University Hospital Cologne, Cologne, Germany.; Cancer Center Cologne Essen (CCCE), Cologne, Germany.; Cologne Lymphoma Working Group, Cologne, Germany.
Bucaciuc-Mracica T; Institute for Computational Cancer Biology, Center for Integrated Oncology, Cancer Research Center Cologne Essen, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
Schwarz RF; Institute for Computational Cancer Biology, Center for Integrated Oncology, Cancer Research Center Cologne Essen, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.; Berlin Institute for the Foundations of Learning and Data, Berlin, Germany.
Rueß D; Department of Stereotaxy and Functional Neurosurgery, Center of Neurosurgery, Faculty of Medicine and University Hospital Cologne, Cologne, Germany.
Ruge MI; Department of Stereotaxy and Functional Neurosurgery, Center of Neurosurgery, Faculty of Medicine and University Hospital Cologne, Cologne, Germany.
Montesinos-Rongen M; Institute of Neuropathology, University of Cologne, Medical Faculty and University Hospital Cologne, Cologne, Germany.
Deckert M; Institute of Neuropathology, University of Cologne, Medical Faculty and University Hospital Cologne, Cologne, Germany.
Blau T; Institute of Neuropathology, University of Duisburg-Essen, University Hospital Essen, Essen, Germany.
Kutsch N; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Medical Faculty and University Hospital Cologne, Cologne, Germany.; Cancer Center Cologne Essen (CCCE), Cologne, Germany.; Cologne Lymphoma Working Group, Cologne, Germany.
Balke-Want H; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Medical Faculty and University Hospital Cologne, Cologne, Germany.; Cancer Center Cologne Essen (CCCE), Cologne, Germany.; Cologne Lymphoma Working Group, Cologne, Germany.; Stanford Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University, Stanford, CA.
Weiss J; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Medical Faculty and University Hospital Cologne, Cologne, Germany.
Becker K; West German Genome Center, University of Cologne, Cologne, Germany.
Reinhardt HC; Department of Hematology and Stem Cell Transplantation, West German Cancer Center and German Cancer Consortium (Deutsches Konsortium für Translationale Krebsforschung partner site Essen), University Hospital Essen, University of Duisburg-Essen, Essen, Germany.; CCCE, Essen, Germany.
Hallek M; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Medical Faculty and University Hospital Cologne, Cologne, Germany.; Cancer Center Cologne Essen (CCCE), Cologne, Germany.
Borchmann P; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Medical Faculty and University Hospital Cologne, Cologne, Germany.; German Hodgkin Study Group, Cologne, Germany.
von Tresckow B; German Hodgkin Study Group, Cologne, Germany.; CCCE, Essen, Germany.
Borchmann S; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Medical Faculty and University Hospital Cologne, Cologne, Germany.; Cancer Center Cologne Essen (CCCE), Cologne, Germany.; Cologne Lymphoma Working Group, Cologne, Germany.; German Hodgkin Study Group, Cologne, Germany.
Pokaż więcej
Źródło :
Blood [Blood] 2024 Feb 08; Vol. 143 (6), pp. 522-534.
Typ publikacji :
Journal Article
MeSH Terms :
Circulating Tumor DNA*/genetics
Central Nervous System Neoplasms*/diagnosis
Central Nervous System Neoplasms*/genetics
Central Nervous System Neoplasms*/therapy
Lymphoma, Non-Hodgkin*
Humans ; Neoplasm Recurrence, Local ; Prognosis ; Biomarkers, Tumor/genetics ; Central Nervous System
Czasopismo naukowe
Tytuł :
Genome-wide DNA methylation profiling for central nervous system embryonal tumours in children: abridged secondary publication.
Autorzy :
Liu APY; Department of Paediatrics and Adolescent Medicine, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China.; Department of Paediatrics and Adolescent Medicine, Hong Kong Children's Hospital, Hong Kong SAR, China.
Chan GCF; Department of Paediatrics and Adolescent Medicine, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China.; Department of Paediatrics and Adolescent Medicine, Hong Kong Children's Hospital, Hong Kong SAR, China.
Chung BHY; Department of Paediatrics and Adolescent Medicine, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China.
Yang W; Department of Paediatrics and Adolescent Medicine, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China.
Ng HK; Department of Anatomical and Cellular Pathology, The Chinese University of Hong Kong, Hong Kong SAR, China.
Pokaż więcej
Źródło :
Hong Kong medical journal = Xianggang yi xue za zhi [Hong Kong Med J] 2024 Feb; Vol. 30 Suppl 1 (1), pp. 29-33.
Typ publikacji :
Journal Article
MeSH Terms :
Central Nervous System Neoplasms*/genetics
Central Nervous System Neoplasms*/pathology
Neoplasms, Germ Cell and Embryonal*/genetics
Child ; Humans ; DNA Methylation ; Central Nervous System/pathology
Czasopismo naukowe
Tytuł :
All-cause and tumor-specific mortality trends in elderly primary central nervous system lymphoma (PCNSL) patients: a surveillance, epidemiology, and end results (SEER) analysis.
Autorzy :
Furst T; Department of Neurosurgery, SUNY Upstate Medical University, Syracuse, NY, USA - .
Hoffman H; Department of Neurosurgery, SUNY Upstate Medical University, Syracuse, NY, USA.
Chin LS; Department of Neurosurgery, SUNY Upstate Medical University, Syracuse, NY, USA.
Pokaż więcej
Źródło :
Journal of neurosurgical sciences [J Neurosurg Sci] 2024 Feb; Vol. 68 (1), pp. 44-50. Date of Electronic Publication: 2019 Oct 08.
Typ publikacji :
Journal Article
MeSH Terms :
Neoplasms*
Lymphoma*/surgery
Lymphoma*/epidemiology
Central Nervous System Neoplasms*/epidemiology
Central Nervous System Neoplasms*/surgery
Aged ; Male ; Humans ; Female ; Prognosis ; Central Nervous System
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies